Erythropoietin solution formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/00 (2006.01)

Patent

CA 2545880

A stable pharmaceutical formulation of erythropoietin is disclosed which contains tris-(hydroxymethyl)-aminomethane as stabilizer, whereby the formulation does not contain amino acids or human serumalbumin.

L'invention concerne une formulation pharmaceutique stable d'érythropoïétine qui contient du tris-(hydroxyméthyl)-aminométhane en tant que stabilisateur, mais qui ne contient ni acides aminés, ni sérumalbunine humaine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Erythropoietin solution formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythropoietin solution formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin solution formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1665948

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.